Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
Kahn Brothers Group Portfolio 13F
Kahn Brothers Group Holdings Activity
- Portfolio value:
- $614.81M≈ (-$73M≈)
- Previous value:
- $687.33M≈
- # of changes:
- 33
- New positions:
- 1
- Reported for:
- 30 Sep 2014 (Q3)
- Latest filing date:
- 06 Nov 2014
Kahn Brothers Group has disclosed a total of 33 changes to the portfolio in the (2014 Q3) SEC report(s): increased the number of shares of 4, bought 1 totally new and decreased the number of shares of 28 position(s).
What stocks did Kahn Brothers Group buy in 2014 Q3?
During 2014 Q3 Kahn Brothers Group has purchased 5 securities: (NVS) Novartis AG ADR (added shares +15.17%), (GSK) GlaxoSmithKline PLC ADR (new buy), (CMCSA) Comcast Corp (added shares +9.00%), (IBM) International Business Machines (added shares +122.77%) and (FFIC) Flushing Financial Corp (added shares +53.36%).
In the 2014 Q3 report(s) the following changes have been made to the top investments: (MRK) Merck & Company Inc (reduced shares -0.97%), (C) Citigroup Inc (reduced shares -11.30%), (PFE) Pfizer Inc (reduced shares -6.56%), (FLG) Flagstar Financial, Inc (reduced shares -5.38%) and (NYT) New York Times Company (reduced shares -1.87%).
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.